Brian Bucher
University of Pittsburgh
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Brian Bucher.
Transplantation | 2005
Allan Tsung; Takashi Kaizu; Atsunori Nakao; Lifang Shao; Brian Bucher; Mitchell P. Fink; Noriko Murase; David A. Geller
Background. Hepatic ischemia-reperfusion injury (I/R) occurs in the settings of transplantation, trauma, and elective liver resections. Reactive oxygen species (ROS) have been shown to play a major role in organ I/R injury. Pyruvate, a key intermediate in cellular metabolism, is an effective scavenger of ROS. The purpose of this study was to test the hypothesis that ethyl pyruvate (EP), a soluble pyruvate derivative, is effective in preventing hepatic I/R injury. Methods. Lewis rats underwent 60 minutes of partial warm hepatic ischemia. Three doses of EP dissolved in lactated Ringer’s solution or lactated Ringer’s solution (LR) alone were given by intravenous injection. Serum and tissue samples were obtained at 1 to 24 hours postreperfusion. Results. Serum transaminases, degree of hepatic necrosis, and neutrophil infiltration were all significantly decreased in the EP-treated rats compared with control animals. The amount of hepatic lipid peroxidation was also significantly decreased in EP-treated animals. Both circulating levels and hepatic expression of inflammatory cytokines were significantly decreased in the EP-treated animals. Furthermore, EP inhibited activation of extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase mitogen-activated protein kinases, as well as nuclear factor-&kgr;B, signaling pathways involved in cytokine release. Treatment with EP also inhibited hepatic apoptosis. Conclusion. EP has a protective effect on hepatic I/R injury, mediated in part by decreasing lipid peroxidation, down-regulation of inflammatory mediators, and inhibition of apoptosis. Strategies using this additive to LR solution should be considered in clinical settings of ischemic liver injury to decrease organ damage.
Tetrahedron Letters | 2000
Brian Bucher; Dennis P. Curran
Abstract Fluorous tin oxide (C6F13CH2CH2)2SnO is readily synthesized, exhibits spectra that are generally similar to dibutyltin oxide and appears to exist as an oligomer or polymer. The fluorous tin oxide can be used catalytically to effect the selective monotosylation of 1,2-diols with TsCl/Et3N, and it can be readily recovered and reused.
Surgery | 2003
Eric L. Marderstein; Brian Bucher; Zhong Guo; Xuesheng Feng; Kaye Reid; David A. Geller
Hepatology | 2006
Takashi Kaizu; Atsushi Ikeda; Atsunori Nakao; Yoshihito Takahashi; Allan Tsung; Junichi Kohmoto; Hideyoshi Toyokawa; Lifang Shao; Brian Bucher; Koji Tomiyama; Michael A. Nalesnik; Noriko Murase; David A. Geller
Journal of Surgical Research | 2007
Brian Bucher; Xuesheng Feng; Geetha Jeyabalan; Baochun Zhang; Lifang Shao; Zhong Guo; David A. Geller
Organic Syntheses | 2002
M. Fengler-Veith; O. Schwardt; U. Kautz; B. Krämer; V. Jäger; Brian P. Haney; Brian Bucher; Dennis P. Curran
The FASEB Journal | 2008
Zhong Guo; Brian Bucher; Lifang Shao; David A. Geller
Journal of Surgical Research | 2006
Brian Bucher; Geetha Jeyabalan; Takashi Kaizu; Xuesheng Feng; Noriko Murase; David A. Geller
Journal of Surgical Research | 2006
Atsushi Ikeda; Takashi Kaizu; Atsunori Nakao; Lifang Shao; Brian Bucher; Noriko Murase; David A. Geller
Transplantation | 2004
Takashi Kaizu; L Sonis; E L. Marderstein; S L. Gleixner; Lifang Shao; Brian Bucher; Atsunori Nakao; Leo E. Otterbein; Augustine M. K. Choi; David A. Geller; Noriko Murase